Workflow
Half-year report on the liquidity contract as of December 31, 2024
PLXProtalix BioTherapeutics(PLX) GlobeNewswire·2025-01-09 07:45

Company Overview - Pluxee is a global leader in Employee Benefits and Engagement, operating in 29 countries with a focus on Meal & Food, Wellbeing, Lifestyle, Reward & Recognition, and Public Benefits [2] - The company serves over 500,000 clients, 37 million+ consumers, and 1.7 million+ merchants, supported by more than 5,000 team members and advanced technology [2] - Pluxee has been in business for over 45 years, emphasizing positive community impact, employee wellbeing, and environmental sustainability [2] Liquidity Contract Summary - As of December 31, 2024, the liquidity account held 200,439 Pluxee N.V. ordinary shares valued at €5,878,911 [4] - During the period from July 1, 2024, to December 31, 2024, the company purchased 972,323 ordinary shares worth €19,626,472 across 6,377 transactions and disposed of 848,300 ordinary shares worth €17,195,841 across 5,661 transactions [4] - In the previous half-yearly report as of June 30, 2024, the liquidity account held 59,130 Pluxee N.V. ordinary shares valued at €8,621,644 [4] - From January 31, 2024, to June 30, 2024, the company purchased 723,308 ordinary shares worth €19,930,588 across 5,132 transactions and disposed of 719,315 ordinary shares worth €19,933,554 across 4,627 transactions [4] - The liquidity account started with €10,000,000 as of January 31, 2024 [4]